Proteomics

Dataset Information

0

Critical Assessment of Metaproteome Investigation (CAMPI): a Multi-Lab Comparison of Established Workflows


ABSTRACT: Metaproteomics, the study of the collective proteome within a microbial ecosystem, has substantially grown over the past few years. This growth comes from the increased awareness that it can powerfully supplement metagenomics and metatranscriptomics analyses. Although metaproteomics is more challenging than single-species proteomics, its added value has already been demonstrated in various biosystems, such as gut microbiomes or biogas plants. Because of the many challenges, a variety of metaproteomics workflows have been developed, yet it remains unclear what the impact of the choice of workflow is on the obtained results. Therefore, we set out to compare several well-established workflows in the first community-driven, multi-lab comparison in metaproteomics: the critical assessment of metaproteome investigation (CAMPI) study. In this benchmarking study, we evaluated the influence of different workflows on sample preparation, mass spectrometry acquisition, and bioinformatic analysis on two samples: a simplified, lab-assembled human intestinal sample and a complex human fecal sample. We find that the same overall biological meaning can be inferred from the metaproteome data, regardless of the chosen workflow. Indeed, taxonomic and functional annotations were very similar across all sample-specific data sets. Moreover, this outcome was consistent regardless of whether protein groups or peptides, or differences at the spectrum or peptide level were used to infer these annotations. Where differences were observed, those originated primarily from different wet-lab methods rather than from different bioinformatic pipelines. The CAMPI study thus provides a solid foundation for benchmarking metaproteomics workflows, and will therefore be a key reference for future method improvement.

INSTRUMENT(S): Orbitrap Fusion Lumos, Q Exactive HF

ORGANISM(S): Homo Sapiens (human) Escherichia Coli

SUBMITTER: Kay Schallert  

LAB HEAD: Thilo Muth

PROVIDER: PXD023217 | Pride | 2022-02-16

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
F01_Fraction1.mgf Mgf
F01_Fraction1.raw Raw
F01_Fraction1_DB1IGC.xml Xml
F01_Fraction1_DB2MG.xml Xml
F01_Fraction2.mgf Mgf
Items per page:
1 - 5 of 172
altmetric image

Publications

Critical Assessment of MetaProteome Investigation (CAMPI): a multi-laboratory comparison of established workflows.

Van Den Bossche Tim T   Kunath Benoit J BJ   Schallert Kay K   Schäpe Stephanie S SS   Abraham Paul E PE   Armengaud Jean J   Arntzen Magnus Ø MØ   Bassignani Ariane A   Benndorf Dirk D   Fuchs Stephan S   Giannone Richard J RJ   Griffin Timothy J TJ   Hagen Live H LH   Halder Rashi R   Henry Céline C   Hettich Robert L RL   Heyer Robert R   Jagtap Pratik P   Jehmlich Nico N   Jensen Marlene M   Juste Catherine C   Kleiner Manuel M   Langella Olivier O   Lehmann Theresa T   Leith Emma E   May Patrick P   Mesuere Bart B   Miotello Guylaine G   Peters Samantha L SL   Pible Olivier O   Queiros Pedro T PT   Reichl Udo U   Renard Bernhard Y BY   Schiebenhoefer Henning H   Sczyrba Alexander A   Tanca Alessandro A   Trappe Kathrin K   Trezzi Jean-Pierre JP   Uzzau Sergio S   Verschaffelt Pieter P   von Bergen Martin M   Wilmes Paul P   Wolf Maximilian M   Martens Lennart L   Muth Thilo T  

Nature communications 20211215 1


Metaproteomics has matured into a powerful tool to assess functional interactions in microbial communities. While many metaproteomic workflows are available, the impact of method choice on results remains unclear. Here, we carry out a community-driven, multi-laboratory comparison in metaproteomics: the critical assessment of metaproteome investigation study (CAMPI). Based on well-established workflows, we evaluate the effect of sample preparation, mass spectrometry, and bioinformatic analysis us  ...[more]

Similar Datasets

2022-06-08 | MSV000089620 | MassIVE
| PRJEB42466 | ENA
| PRJNA638427 | ENA
2023-09-20 | PXD045538 |
2019-02-12 | PXD008017 | Pride
2022-02-16 | PXD021932 | Pride
2020-04-06 | MSV000085239 | MassIVE
| PRJNA763390 | ENA
2024-05-31 | PXD049294 | Pride
2022-02-15 | PXD020695 | Pride